Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population
Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population
Recruiting · NCT05837884 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population | Healthy | Recruiting | Not stated | 2026-08-11 | NCT05837884 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| Tel-Aviv Sourasky Medical Center | 55 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rabin Medical Center | Petah Tikva | Israel | 33 |
| Rambam Healthcare Campus | Haifa | Israel | 3 |
| Soroka | Beersheba | Israel | 1 |
| TASMC | Tel Aviv | Israel | 1 |